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ABSTRACT
Background: Non-medical professionals including pharmacists have been granted the right to prescribe 
medicines in the United Kingdom. In Nigeria, only medical doctors, dentists and some nurses in primary care 
facilities have the legal right to prescribe medicines and patients' access to prescriptions can be seriously 
affected by a shortage of prescribers and long waiting times in hospitals. 
Objective: This article presents a review of pharmacist prescribing in the UK including its model, impact, 
facilitators and barriers and discusses the implications for the Nigerian context. 
Methods: A literature search was conducted in Medline, Embase, International Pharmaceutical Abstracts and 
Cumulative Index to Nursing and Allied Health Literature databases for studies investigating pharmacist 
prescribing in the UK between 1990 and August 2013.
Results: The review identified that legislative change in the UK has enabled pharmacists to prescribe first as 
supplementary prescribers then as independent prescribers. This policy change was driven by the desire to 
increase patients' access to medicines and promote the utilisation of the skills of non-medical professionals 
while maintaining patient safety. Although more robust research evidence is needed to demonstrate the 
effectiveness of pharmacist prescribing, available evidence shows that it has had an impact on patient access 
to medicines.
Conclusion: Pharmacist prescribing has the potential to promote access to prescription medicines, free 
doctors' time to enable them deal with complex cases and promote efficient use of pharmacists' clinical skills 
in Nigeria as it does in the UK. Factors which can promote the extension of prescribing rights to pharmacists in 
Nigeria include the current level of pharmacists' training and the clinical roles of pharmacists in some tertiary 
hospitals. 
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RESUME
Contexte: Les professionnels non-médicaux y compris les pharmaciens ont reçu le droit de prescrire des 
médicaments au Royaume-Uni. Au Nigeria, seuls les médecins, les dentistes et certains infirmiers dans les 
établissements de soins primaires ont le droit de prescrire des médicaments et l'accès des patients aux 
prescriptions peut gravement être affecté par un manque de prescripteurs et par de longues périodes 
d'attente dans les hôpitaux. 
Objectif: Cet article présente un bilan sur les prescriptions par les pharmaciens au Royaume-Uni y compris le 
modèle, les répercussions, les animateurs et les barrières et traite les implications pour le contexte nigérian. 
Méthodes: Une recherche documentaire a été menée à Medline, Embase, International Pharmaceutical 
Abstracts and Cumulative Index to Nursing and AlliedHealthLiteraturedatabases pour des enquêtes sur la 
prescription des pharmaciensau Royaume-Uni entre 1990 et août 2013.
Résultats: Le bilan a identifié qu'un changement législatif au Royaume-Uni a autorisé les pharmaciens à 
prescrire d'abord en tant que prescripteurs complémentaires, puis en tant que prescripteurs indépendants. 
Ce changement de politique fut mené par le désir de renforcer l'accès des patients aux médicaments et 
promouvoir l'utilisation des compétences des professionnels non-médicaux tout en maintenant la sécurité 
des patients. Bien qu'il soit nécessaire de trouver des preuves de recherches robustes pour démontrer 
l'efficacité de la prescription des pharmaciens, les preuves disponibles montrent que cela a eu des 
répercussions sur l'accès du patient aux médicaments.
Conclusion: La prescription par les pharmaciens a le potentiel de promouvoir l'accès aux médicaments 
d'ordonnance, de donner du temps aux docteurs pour leur permettre de traiter des cas plus complexes et 
promouvoir l'usage efficace des compétences cliniques des pharmaciens au Nigéria comme c'est le cas au 
Royaume-Uni. Les facteurs qui contribuent à l'extension des droits de prescription aux pharmaciens 
comprennent le niveau actuel de la formation des pharmaciens et les rôles cliniques des pharmaciens dans 
certains hôpitaux tertiaires.
Mots clés: pharmacien prescripteur, Nigéria, Royaume-Uni
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Pharmacist prescribing in the UK
INTRODUCTION
Prescribing to patients has been the exclusive role of 
doctors and dentists until the introduction of non-
medical prescribing (NMP) in some countries which 
allowed healthcare professionals including nurses and 
1pharmacists to prescribe some medicines.  A number of 
countries have made legislation concerning pharmacist 
prescribing including the USA, UK, Canada, South Africa 
2, 3and New Zealand.   However, prescribing rights for 
pharmacists are not the same in all of these countries. 
For example, in the UK, pharmacists can prescribe any 
medicine (except some specific controlled drugs for 
4treating addiction) within their area of competence,  
while in South Africa pharmacists are only allowed to 
2prescribe from a limited formulary.
In Nigeria, only medical doctors and dentists have the 
legal right to prescribe medicines. However, a nurse or a 
community health worker can be designated by the 
government to prescribe medicines in a primary 
5healthcare facility without a doctor.  Access to 
medicines in Nigeria can be seriously affected by the 
shortage of medical prescribers (40 doctors per 100,000 
people compared with 280 doctors per 100,000 people 
6in the UK);  long waiting times in hospitals and poor 
7geographical access to physicians.   Typically, a doctor in 
an out-patient department in a teaching hospital in 
Nigeria has approximately 40 – 50 patient consultations 
daily and more than half of these patients wait for more 
than an hour in the out-patient department  before 
7seeing a doctor.
Pharmacists in Nigeria are highly educated 
professionals with adequate training in medicine 
management. Their mode of training follows similar 
models to those in advanced countries including the 
8UK.  It consists of a five-year undergraduate 
professional programme followed by one-year pre-
8registration work-based supervised training.  Despite 
the cost and high level of training of pharmacists in 
Nigeria, their expertise is not always utilised effectively 
as their roles have not been expanded to a more clinical 
one. They mainly perform the traditional role of 
dispensing, which could be handled by suitably trained 
pharmacy technicians as in other countries such as the 
UK.  
Pharmacists in Nigeria have shown willingness for 
9expanded clinical roles including prescribing. Hence, 
this article reviewed pharmacist prescribing in the UK 
including its models, impact, facilitators and barriers 
and discussed the implications for the Nigerian context.
 METHODS
We conducted a review of pharmacist prescribing in the 
UK. A literature search was conducted in Medline, 
Embase, International Pharmaceutical Abstracts (IPA) 
and Cumulative Index to Nursing and Allied Health 
Literature (CINAHL) databases. Search terms including 
pharmacist prescribing, supplementary prescribing, 
independent prescribing, and non-medical prescribing 
were used. Search techniques including combination of 
search terms using 'AND/OR', adjacency searching and 
truncation were employed. Additional literature search 
was also conducted on Google scholar and the 
Department of Health (DoH) website to identify 
relevant grey literatures including policy documents and 
research reports.
Studies investigating pharmacist prescribing in the UK 
between January 1990 and August 2013 were 
considered. Research investigating nurse and 
pharmacist prescribing, major research reports and 
documents from the UK Department of Health were 
also included. Additional articles were identified 
through cross-references. Where more than one 
publication present the same or similar findings, the 
most recent publication or the one with a detailed 
description of the methods and findings was 
considered. All the articles considered for this review 
were published in the English Language.
RESULTS
Models and levels of pharmacist prescribingin the UK 
Two models of pharmacist prescribing are identifiable in 
the UK namely supplementary prescribing and 
independent prescribing which were introduced in 2003 
10and 2006, respectively.  Supplementary prescribing 
involves a “voluntary partnership between an 
independent prescriber (a doctor or dentist) and a 
supplementary prescriber to implement an agreed 
patient-specific clinical management plan with the 
10patient's agreement”.  In the independent prescribing 
model, the prescriber 
“is responsible and accountable for the assessment of 
patients with undiagnosed or diagnosed conditions and 
for decisions about the clinical management required, 
10including prescribing”.
To qualify as a pharmacist independent prescriber 
(which now includes a qualification as a supplementary 
prescriber), a pharmacist must have at least 2 years 
post-registration experience in a patient-orientated 
environment, undergo study at university level 
equivalent to 26 days of full-time education and at least 
a 12-day period of learning in practice with a designated 
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1medical practitioner.   Core components of a 
pharmacist prescribing course include  consultation, 
decision making, assessment and review; psychology of 
prescribing; prescribing in team context; applied 
therapeutics; evidence-based practice and clinical 
governance; legal, policy, professional and ethical 
1aspects; and prescribing in the public health context.  
Pharmacist prescribers are expected to develop a 
number of competencies including recognising signs 
and symptoms of illness, using relevant diagnostic aids, 
1and clinical assessment skills.
There are approximately 2400 registered pharmacist 
1supplementary/independent prescribers in the UK.  
These prescribers are able to prescribe medicines for 
any condition within their clinical competence but not 
cocaine, dipipanone and diamorphine for treating 
4addiction.  However, pharmacist prescribers in the UK 
usually prescribe in one clinical area and this has been 
criticized for its limited scope and inability to meet the 
11needs of patients with multiple conditions.
Impact of pharmacist prescribing
Findings from the literature were consistent across 
various stakeholders including doctors, pharmacists, 
patients, and policymakers in reporting an increase in 
patients' access to treatment as a result of NMP, and a 
12,13,14perceived reduction in delays to appointments.
Research evidence demonstrating any improvement in 
outcome to patient therapy due to pharmacist 
15 15prescribing is limited.  However, Bruhn et al.,  
conducted an exploratory randomised control trial 
(RCT) in the UK to compare the effectiveness of 
pharmacist medication review, with or without 
pharmacist prescribing, with standard care, for patients 
with chronic pain. The RCT involved 196 chronic pain 
patients (from six general practices) randomised into 
three study groups: pharmacist medication review with 
pharmacist prescribing (n=70); pharmacist medication 
review with feedback to GP and no planned patient 
contact (n=63); and treatment as usual group (n=63). 
Patients in the pharmacist prescribing group showed 
significant improvement in some clinical outcomes 
(including chronic pain grade) after six months of 
follow-up. This suggests that pharmacist prescribing 
could result in improvement in pain-related outcomes.  
Studies exploring patients' experience of pharmacist 
prescribing have reported positive benefits including 
pharmacists' approachability, better patient education 
11,12and extended consultation time. Despite these 
benefits, some patients have reported that they would 
prefer to consult a doctor for a prescription, especially 
for initial diagnosis or when their illness is considered 
11serious.
Doctors have reported positive benefits of pharmacist 
prescribing including comprehensive medication 
review, keeping doctors' medicine knowledge updated, 
and freeing doctors' time to allow for other specialised 
16responsibilities.  However, some doctors reported that 
pharmacist prescribing is likely to result in the deskilling 
17of junior doctors.  There are assertions that NMP 
reduces doctors' workload; however, no research has 
18clearly demonstrated this.  What is usually reported in 
most studies is a shift or reorganisation of tasks and it is 
uncertain whether this has resulted in an overall 
reduction in doctors' workload.
Pharmacists have also reported positive impacts on 
their role to include: enhanced job satisfaction; better 
use of their clinical skills; recognition of the 
pharmacists' role in patient care by other healthcare 
professionals; integration into the patient management 
team and more autonomy and responsibility in patient 
12,17,19management.  A survey conducted among 105 
qualified pharmacist prescribers in Northern Ireland 
found that those who were prescribing, were more 
likely to report enhanced job satisfaction than those 
19who qualified as prescribers but had never prescribed.
Facilitators to pharmacist prescribing
The legislative change (Health and Social Care Act, 
2001) following the recommendations of the Crown 
reports, enabled nurses and pharmacists to prescribe 
first as supplementary prescribers then as independent 
prescribers in the UK. This policy change was driven by 
the desire to increase patients' access to medicines and 
to promote the utilisation of the skills of non-medical 
10professionals while maintaining patient safety.
The literature shows that the implementation of 
pharmacist prescribing in the UK was aided by the 
changes that occurred in the professional structure of 
pharmacy (especially within the hospital setting) prior 
17,20to the introduction of pharmacy prescribing.  
Between the 1970s and the 1980s, there was a change 
in hospital pharmacy practice that saw the 
development of clinical pharmacy services with 
pharmacists contributing to prescribing decisions, 
monitoring and modifying patient therapy among other 
20clinical roles.  Further development in clinical 
pharmacy practice led to specialisation in different 
clinical practice areas including cardiovascular, renal, 
diabetes and clinical nutrition which facilitated the 
development of supplementary prescribing in these 
18areas.  Pharmacy technician roles in the UK were also 
expanded to include selection and labelling of 
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dispensed items, accuracy checks, medicine stock 
20checks, etc.  This optimal use of the skills of pharmacy 
support staff resulted in freeing-up pharmacists' time to 
concentrate on advanced clinical roles. 
Furthermore, the advancement in pharmacy education 
and training with increasing integration of clinical 
pharmacy practice at both the undergraduate and 
postgraduate levels was also an important facilitator to 
21pharmacist prescribing in the UK.  The European Union 
Working Time Directive which limit doctors' weekly 
working hours, initially to 58 hours (in August, 2004), 
and then to 48 hours by 2009 also necessitated role 
22extension to non-medical professionals in the UK.  
Other factors including effective teamwork among 
hospital staff and community pharmacists' accessibility 
were also reported as facilitators to the implementation 
17of pharmacist prescribing in the UK.
Barriers to pharmacist prescribing
Although there are reports showing support for 
supplementary prescribing by doctors, especially 
12,17mentors of supplementary prescribers,  research has 
shown that doctors were usually less supportive of 
p h armac i st  in d ep en d ent  p res cr ib in g  th an  
12,17supplementary prescribing.  The main concerns of 
the medical profession, as revealed in the literature, 
centred on threats to medical dominance, professional 
boundary encroachment, deskilling of junior doctors 
and inadequate skills of pharmacists in clinical 
12,17examination and diagnosis.
Barriers to the implementation of pharmacist 
prescribing reported in empirical studies were mainly 
organisational. Early barriers to the implementation of 
supplementary prescribing reported included 
inadequate funding for training and setting up 
prescribing services, lack of organisational recognition 
and policies to support NMP in some trusts, lack of 
awareness among patients and healthcare 
professionals, delay in obtaining prescription pads, 
problems in generating electronic prescriptions, lack of 
access to patient records, and paperwork and 
restriction due to the creation of the patient-specific 
23clinical management plan.
The literature also revealed that the implementation of 
pharmacist prescribing within the community 
pharmacy setting is poor. For example, a questionnaire 
survey conducted in the UK among 401 pharmacists to 
explore their early experience as supplementary 
prescribers, revealed that respondents in other practice 
settings including hospital and primary care medical 
practice were three times more likely to prescribe than 
23those in community pharmacy settings.   Barriers 
associated with prescribing in community pharmacy 
settings included difficulty in accessing patient records, 
lack of privacy, inadequate support staff, and lack of 
collaborations between community pharmacists and 
23GPs.
DISCUSSION
This review demonstrated that pharmacist prescribing 
has the potential to increase patients' access to 
medicines, promote efficient use of pharmacists' skills, 
free-up doctors' time to concentrate on complex cases 
and reduce delays to appointments. This would be of 
major benefit to Nigeria. However, pharmacist 
prescribing would be more beneficial in the Nigerian 
context if pharmacist prescribers were trained and 
prepared to prescribe across multiple conditions and 
were able to treat comorbid conditions within their 
clinical area. For example, a pharmacist prescriber in 
the clinical area of HIV should be able to treat HIV and 
tuberculosis co-infection since co-infection is common. 
This will make effective use of the available limited 
human resources rather than referring patients with 
comorbidity to a doctor. 
Furthermore, a number of reports have shown that 
patients have unhindered access to prescription 
medicines (without a prescription) through various 
authorised and unauthorised sources including 
community pharmacies and patent medicine 
24,25vendors.  This is possible because of the  poor 
regulation of the distribution and sales of medicines in 
24,25 Nigeria.
24.  Nevertheless, 
this practice is harmful as it often results in irrational use 
of medicines. Although proper regulation and 
enforcement of laws governing the sale and distribution 
of medicines is essential in curtailing this practice, 
pharmacist prescribing could minimise this illegal 
access to prescription medicines and reduce medicines 
harm in community pharmacies where there is a 
pharmacist prescriber. 
A number of facilitators to the introduction of 
pharmacist prescribing are identifiable in the Nigerian 
context including the current level of training of 
pharmacists and the clinical roles of some hospital 
pharmacists. In Nigeria, clinical pharmacy was 
introduced into undergraduate pharmacy training in 
26 1990. Today, clinical pharmacy courses are well 
established in undergraduate and postgraduate 
Although many factors could account for patients’ 
involvement in such practice, the cost of getting a 
prescription from a medical prescriber and difficulty in 
access to medical prescribers due to long waiting times 
in hospitals have been cited by patients
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pharmacy programmes.  In addition, many pharmacists 
in Nigeria specialise as clinical pharmacists at various 
universities and at the West African Postgraduate 
27 College of Pharmacists. About two-thirds of the 482 
Nigerian pharmacists who successfully completed the 
WAPCP fellowship programme as of 2011 were in the 
27specialty of clinical pharmacy. Furthermore, many 
tertiary hospitals in Nigeria have decentralised their 
pharmacy units into specialised units including 
paediatric, medical, intensive care, oncology, surgical, 
accident and emergency pharmacy in order to meet 
patients' care need. This change in structure can be 
used to promote specialisation in these clinical areas. 
Also, anecdotal evidence has shown that some Nigerian 
pharmacists in secondary and tertiary hospitals are 
involved in clinical ward rounds with doctors, during 
which they review patients' medications, contribute to 
prescribing decisions and monitor patient therapy. This 
professional relationship between doctors and 
pharmacists could potentially facil itate the 
implementation of supplementary or collaborative 
prescribing. 
Community pharmacists' accessibility and the reliance 
of patients on them for the treatment of their minor 
illnesses could potentially facilitate pharmacist 
prescribing in Nigeria. A report by the World Bank 
showed that about 25% of diarrhoea and 33% of fever 
or cough cases in children in Nigeria were treated in 
28community pharmacies. A recent survey conducted 
among 432 clients of community pharmacist that 
explored their perception on pharmacist prescribing in 
29Nigeria revealed a high support (91.4%) for it.  These 
respondents commonly cited improving access to 
prescriptions as their reason for supporting pharmacist 
prescribing. However, over two-third of these 
respondents were more comfortable with the 
pharmacist prescribing from a limited formulary. These 
findings are suggestive of patients' acceptance for 
pharmacist prescribing in Nigeria.
The medical profession is likely to be a major opposition 
to pharmacist prescribing in Nigeria. Some reports, 
30including that of Erah (2003),  have reported 
opposition from doctors as a barrier to extending 
clinical roles of pharmacists in Nigeria because doctors 
consider some of the extended pharmacy roles as an 
encroachment into their professional boundaries. 
However, if supplementary prescribing is initially 
proposed in the Nigerian context (as was in the UK), this 
opposition may be overcome. The medical profession 
favours supplementary prescribing because it 
18 maintains doctors' control of the prescribing process.
Supplementary prescribing model would also foster 
collaboration between doctors and pharmacists and 
provide the prescribing pharmacists the opportunity to 
learn from the medical prescriber especially in the 
aspect of differential diagnosis and the experience 
gained would be essential if independent prescribing 
was subsequently implemented.
Another likely barrier to pharmacist prescribing in 
Nigeria is the shortage of pharmacy staff including 
pharmacists and pharmacy technicians. There are 
approximately 16,000 (10 per 100,000 population) 
31pharmacists in Nigeria, compared to the UK with about 
42,000 practicing pharmacists (68 per 100,000 
32people).   As at 2007, there were 5483 pharmacy 
technicians registered with the Pharmacists' Council of 
33Nigeria.  Anecdotally, a significant additional number 
of pharmacy technicians are not registered with the 
council. This limited population of pharmacists and 
their support staff could serve as a barrier to role 
expansion. However, increasing the utilisation of 
pharmacy technicians could benefit the system. 
Therefore, suitably trained pharmacy technicians would 
be needed to take up some of the traditional roles of 
pharmacists in order to free-up pharmacists' time for 
advanced roles.
Similar to community pharmacists in the UK, lack of 
collaborative practice between doctors and community 
pharmacists; lack of access to patient records; and 
inadequate support staff and infrastructure are likely to 
hinder pharmacist prescribing in community pharmacy 
settings in Nigeria. There is currently no structure in 
place that promotes partnership between doctors and 
community pharmacists or between hospitals and 
community pharmacies in Nigeria. Therefore, sharingof 
patients' information including clinical records between 
these two settings would be a problem and this would 
result in the fragmentation of care.
As with most studies, this review has some limitations. 
Unlike a systematic review, the methodological quality 
of the primary research articles included in this review 
was not assessed. Hence, it is possible that some 
research papers with low methodological quality were 
included. Also, we included grey literatures which are 
likely to impact on the quality of evidence we 
presented. However, research evidence in the field of 
pharmacist prescribing is still emerging and the 
inclusion of grey literatures provided more 
comprehensive information for our review. Finally, our 
literature search was largely conducted using electronic 
databases. Therefore, it is possible that some eligible 
articles that were not indexed on the databases 
searched were excluded. 
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CONCLUSION
Pharmacist prescribing has the potential to promote 
better patient access to prescription medicines; free 
doctors' time to enable them deal with complex cases; 
promote efficient use of pharmacists' clinical skills; 
enhance pharmacists' job satisfaction and their 
contribution to healthcare delivery in Nigeria.  
Facilitators to the extension of prescribing rights to 
pharmacists in Nigeria include the current level of 
pharmacists' training and the clinical roles of 
pharmacists in some tertiary hospitals. However, if 
current pharmacists' roles are to be extended to include 
prescribing, more training and specialisation within 
clinical areas are needed and additional suitably trained 
pharmacy technicians will also be needed to take up 
some of the current roles of pharmacists in order to give 
pharmacists more time for advanced roles.
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